Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women

Clinical trial NCT04283656 · COMPLETED

Trial details

NCT number: NCT04283656
Sponsor: Thomas Jefferson University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Transgender Health Gender Dysphoria Transgender Women Human Immunodeficiency Virus

Start date: 2022-01-04
Primary completion: 2022-10-25
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.